In an editorial published in CNS Spectrums, UK Neurologist Jay Avasarala, MD, PhD, takes the research community to task for its lack of minority representation in Phase III clinical trials for drugs to treat Multiple Sclerosis (MS).
Researchers at the University of Kentucky have discovered new biological processes by which mutations in the FUS gene cause neurodegeneration in amyotrophic lateral sclerosis (ALS).
Research from the Sanders-Brown Center on Aging presented at the Society for Neuroscience annual meeting has identified two potential ways to predict vascular cognitive impairment and dementia (VCID) – the second leading cause of dementia behind Alzheimer's disease.
Two studies from Ai-Ling Lin's lab in the Sanders-Brown Center on Aging demonstrate the effect of diet — specifically the Ketogenic diet and simple caloric restriction — on cognitive health in animals.
A research facility expressly devoted to addressing and eradicating the state’s most significant health disparities was opened September 21st by the University of Kentucky Board of Trustees, President Eli Capilouto and many of the Commonwealth’s leading policymakers.
Results from a survey of more than 1,000 U.S. adults showed that while almost 80 percent of respondents were willing to volunteer for medical research, two-thirds didn't know how to get involved.
A UK neurologist who stumbled across a family with a gene mutation that can cause Lou Gehrig's Disease is merging science, medicine and family in a quest for a cure.
STAT News, a division of the Boston Globe, has published a story about the work of Dr. Edward Kasarskis and his team, who study a familial form of ALS.
The new Center for Health Equity Transformation aims to grow health equity research at the University of Kentucky by training and providing professional development guidance to those interested in studying and addressing health disparities.
A rare, genetic type of ALS seems to cluster in central Appalachia. The TRANSLATE clinical trial, led by a multidisciplinary time of clinicians and scientists, is looking for hope in an existing FDA-approved drug.
